BMJ  2008;336:903-904 (26 April), doi:10.1136/bmj.39547.586100.80

Editorials

Patient and public involvement in clinical trials

Is established worldwide, but encouragement is needed to promote institutional collaboration and avoid duplication of effort

The first 150 words of the full text of this article appear below.

Patient and public involvement in clinical trials has been defined as "experimenting with" as opposed to "experimenting on" patients.¹ It is founded on the belief that a collaborative approach to testing treatments is vital if the uncertainties that matter most to patients are to be reduced.² In 1994, the ethicist Raanon Gillon proposed that not only morality but also scientific interest should combine to urge a "brave new partnership between clinical trialists and patients."³

It is difficult to be precise about the origin of patient and public involvement but several early examples exist. Rose Kushner—a pioneer of patient involvement in the United States in the 1970s—was a freelance writer who also had breast cancer. She wrote a book, which was based on a thorough review of evidence of the effects of radical mastectomy. Her influence and attitude was such that she eventually reviewed new research proposals for the US National . . . [Full text of this article]

¹ Department of Health Sciences, University of Leicester, Leicester LE1 7RH

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Size at birth, maternal nutritional status in pregnancy, and blood pressure at age 17: population based analysis

Arie Laor, David K Stevenson, Jeoshua Shemer, Rena Gale, and Daniel S Seidman
BMJ 1997 315: 449-453. [Abstract] [Full Text]

Rapid Responses:

Read all Rapid Responses

Re: BMJ Editorial, Patient and Public Involvement in Clinical Trials

Peter Littlejohns
bmj.com, 23 May 2008 [Full text]

NICE's ordinaries

Michael O'Donnell
bmj.com, 27 May 2008 [Full text]

Welcome correction

Hazel Thornton
bmj.com, 5 Jun 2008 [Full text]